Partnership for sustainability in cardiac surgery to address critical rheumatic heart disease in sub-Saharan Africa: The experience from Rwanda

World Journal of Surgery

Volumn 38, Issue 9, 2014, Pages 2205-2211

  Swain, Jabaris D ^a,b   Pugliese, Daniel N ^a,b   Mucumbitsi, Joseph ^c,d   Rusingiza, Emmanuel K ^c,e   Ruhamya, Nathan ^c,d   Kagame, Abel ^c,e   Ganza, Gapira ^c,f   Come, Patricia C ^b,g   Breakey, Suellen ^b,h   Greenwood, Bonnie ^a,b   Muehlschlegel, Jochen D ^a,b   Patton Bolman, Cecilia ^b   Binagwaho, Agnes ⁱ   Morton Bolman, R ^a,b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b Team Heart Inc   (United States)

^c Rwanda Heart Foundation   (Rwanda)

^d KING FAISAL HOSPITAL   (Rwanda)

^e Centre Hospitalier Universitaire de Kigali   (Rwanda)

^f Kanombe Military Hospital   (Rwanda)

^g HARVARD VANGUARD MEDICAL ASSOCIATES   (United States)

^h MGH INSTITUTE OF HEALTH PROFESSIONS   (United States)

ⁱ Rwanda Ministry of Health   (Rwanda)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ADVERSE EFFECTS; CAPACITY BUILDING; ECONOMICS; EDUCATION; FEMALE; GOVERNMENT; HEALTH CARE DELIVERY; HEART VALVE REPLACEMENT; HUMAN; MALE; MANPOWER; MIDDLE AGED; NON PROFIT ORGANIZATION; ORGANIZATION AND MANAGEMENT; PATIENT SELECTION; PROGRAM EVALUATION; PUBLIC-PRIVATE PARTNERSHIP; RHEUMATIC HEART DISEASE; RWANDA; SUPPLY AND DISTRIBUTION; SURGICAL EQUIPMENT; TEACHER; TREATMENT OUTCOME; YOUNG ADULT;

ADOLESCENT; ADULT; CAPACITY BUILDING; DELIVERY OF HEALTH CARE; FEMALE; FOUNDATIONS; GOVERNMENT AGENCIES; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; MALE; MENTORS; MIDDLE AGED; PATIENT SELECTION; PROGRAM EVALUATION; PUBLIC-PRIVATE SECTOR PARTNERSHIPS; RHEUMATIC HEART DISEASE; RWANDA; SURGICAL EQUIPMENT; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84905700189     PISSN: 03642313     EISSN: 14322323     Source Type: Journal    
DOI: 10.1007/s00268-014-2559-2     Document Type: Article

References (28)

1. Gaziano TA, Bitton A, Anand S, Abrahams-Gessel S, Murphy A (2010) A growing epidemic of coronary heart disease in low and middle-income countries. Curr Probl Cardiol 35(2):72-115
2. Gaziano TA, Reddy KS, Paccaud F, Horton S, Chaturvedi V (2006) Cardiovascular disease. In: Bremen JG, Measham AR, Jamison DT (eds) Disease control priorities in developing countries. World Bank, Washington
3. Kinsley RH (2012) The third Aldo Castaneda lecture: the neglect of neonatal/infant cardiac disease in Africa-continental genocide? World J Pediatr Congenit Heart Surg 3(2):241-243
4. Kumar RK, Tandon R (2013) Rheumatic fever and rheumatic heart disease: the last 50 years. Indian J Med Res 137:643-658
5. Sliwa Z, Zilla P (2012) Rheumatic heart disease: the tip of the iceburg. Circulation 125(25):3060-3062
6. World Health Organization (2004) Rheumatic fever and rheumatic heart disease report of a WHO expert consultation. World Health Organization, Geneva
7. Marijon E, Ou P, Celermajer DS, Ferreira B, Mocumbi AO, Jani D, Paquet C, Jacob S, Sidi D, Jouven X (2007) Prevalence of rheumatic heart disease detected by echocardiographic screening. N Engl J Med 357:470-476
8. Karthikeyan G, Mayosi BM (2009) Is primary prevention of rheumatic fever the missing link in the control of rheumatic heart disease in Africa? Circulation 120(8):709-713
9. Carapetis JR, Steer AC, Mulholland EK, Weber M (2005) The global burden of group A streptococcal diseases. Lancet Infect Dis 5:685-694
10. Carapentis J (2007) Rheumatic heart disease in developing countries. N Engl J Med 357:439-441
11. Seckeler MD, Hoke TR (2011) The worldwide epidemiology of acute rheumatic fever and rheumatic heart disease. Clin Epidemiol 3:367-384
12. Ehrlich JE, Demopoulos BP, Daniel KR, Ricarte MC, Glied S (2002) Cost-effectiveness of treatment options for prevention of rheumatic heart disease from Group A streptococcal pharyngitis in a pediatric population. Prev Med 35(3):250-257
13. Tsevat J, Kotagal UR (1999) Management of sore throats in children: a cost-effectiveness analysis. Arch Pediatr Adolesc Med 153(7):681-688
14. Bongani MM (2006) A proposal for the eradication of rheumatic fever in our lifetime. SAMJ 96(3):229-230
15. Irlam J, Bongani MM, Engel M, Gaziano TA (2013) Primary prevention of acute rheumatic fever and rheumatic heart disease with penicillin in South African children with pharyngitis: a cost-effectiveness analysis. Circ Cardiovasc Qual Outcomes 6(1):343-351
16. Pezzella TA (2006) Open heart surgery in a developing country. Asian Cardiovasc Thoracic Ann 14(4):355-356
17. Mocumbi AO (2012) The challenges of cardiac surgery for African children. Cardiovasc J Afr 233:165-167
18. Bukhman G, Kidder A (2011) The PIH guide to chronic care integration for endemic non-communicable diseases. Partners in Health, Boston
19. Logie DE, Rowson M, Ngagije F (2008) Innovations in Rwanda's health system: looking to the future. Lancet 372(9634):256-261
20. Mucumbitsi J, et al (2013) Prevalence of rheumatic heart disease: screening of school age children in Gasabo district: phase I. PASCAR Abstract Program
21. Amendezo E, Twagirumukiza M, Sebatunzi O, Kagame A (2008) In hospital cardiovascular morbidity and mortality in the department of internal medicine at CHU Kigali (Rwanda). Ann Trop Med Public Health 1:9-14
22. Velebit B, Montessuit M, Bednarkiewicz M, Khatchatourian G, Mueller X, Neidhart P (2008) The development of cardiac surgery in an emerging country. Tex Heart Inst J 353:301-306
23. Jonas RA (2008) Congenital heart surgery in developing countries. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu. doi: 10.1053/j.pcsu.2007.12.001
24. Saxena A (2009) Congenital cardiac surgery in less privileged regions of the world. Expert Rev Cardiovasc Ther 7(12):1621-1629
25. Falase B, Sanusi M, Mjekodunmi A, Ajose I, Idowu A, Oke D (2013) The cost of open heart surgery in Nigeria. Pan Afr Med J 14:61
26. White H, Walsh W, Brown A, Riddell T, Tonkin A, Jeremy R, Brieger D, Zeitz C, Kritharides L (2010) Rheumatic heart disease in indigenous populations. Heart Lung Circ 19(5-6):273-281
27. Little M (2012) Working toward transformational health partnerships in low- and middle-income countries. Business for Social Responsibility, Reuters
28. Raghavan D, Simionescu DT, Vyavaharu NR (2007) The use of neomycin trisulfate to inhibit enzyme-mediated glycominoglycan degeneration in bioprosthetic heart valves. Biomaterials 28(18):2861-2868